ストックスクリーナーアプリを入手
27.81
0.32%
-0.09
アフターアワーズ：
28.00
0.19
+0.68%
前日終値:
$27.90
開ける：
$27.78
24時間の取引高:
2.11M
Relative Volume:
0.49
時価総額：
$1.73B
収益：
$14.34M
当期純損益:
$-199.00M
株価収益率:
-7.0944
EPS:
-3.92
ネットキャッシュフロー:
$-183.51M
1週間 パフォーマンス:
-6.93%
1か月 パフォーマンス:
-55.91%
6か月 パフォーマンス:
+79.42%
1年 パフォーマンス:
+375.79%
1日の値動き範囲:
$26.20
$28.71
1週間の範囲:
$26.20
$31.38
52週間の値動き範囲:
$5.705
$71.50
Uniqure N V Stock (QURE) Company Profile
QURE を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
QURE
Uniqure N V
|
27.81 | 1.74B | 14.34M | -199.00M | -183.51M | -3.92 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.76 | 107.15B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
755.90 | 77.46B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
436.38 | 58.90B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
918.92 | 56.55B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
198.76 | 42.58B | 447.02M | -1.18B | -906.14M | -6.1812 |
Uniqure N V Stock (QURE) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-11-04 | ダウングレード | William Blair | Outperform → Mkt Perform |
| 2025-08-14 | アップグレード | Mizuho | Neutral → Outperform |
| 2025-04-01 | 再開されました | Chardan Capital Markets | Buy |
| 2024-12-10 | アップグレード | Raymond James | Outperform → Strong Buy |
| 2024-10-10 | 再開されました | Raymond James | Outperform |
| 2024-02-29 | ダウングレード | Goldman | Buy → Neutral |
| 2023-12-19 | ダウングレード | Mizuho | Buy → Neutral |
| 2022-03-17 | アップグレード | UBS | Neutral → Buy |
| 2021-06-15 | 開始されました | BTIG Research | Buy |
| 2021-05-21 | 開始されました | UBS | Neutral |
| 2021-04-26 | 再開されました | Credit Suisse | Outperform |
| 2021-04-01 | アップグレード | Mizuho | Neutral → Buy |
| 2021-01-07 | アップグレード | Guggenheim | Neutral → Buy |
| 2020-11-24 | 開始されました | H.C. Wainwright | Buy |
| 2020-11-11 | 開始されました | Berenberg | Buy |
| 2020-11-09 | 開始されました | Jefferies | Buy |
| 2020-11-04 | 開始されました | Cantor Fitzgerald | Overweight |
| 2020-10-23 | 開始されました | RBC Capital Mkts | Outperform |
| 2020-08-25 | 開始されました | Raymond James | Strong Buy |
| 2020-07-31 | アップグレード | Robert W. Baird | Neutral → Outperform |
| 2020-06-25 | ダウングレード | Mizuho | Buy → Neutral |
| 2020-06-25 | ダウングレード | Robert W. Baird | Outperform → Neutral |
| 2020-06-25 | ダウングレード | Wells Fargo | Overweight → Equal Weight |
| 2019-12-03 | 開始されました | Cowen | Outperform |
| 2019-12-03 | 開始されました | Goldman | Buy |
| 2019-11-05 | 開始されました | Credit Suisse | Outperform |
| 2019-10-11 | 開始されました | Stifel | Buy |
| 2019-09-25 | 開始されました | Bernstein | Outperform |
| 2019-09-12 | 開始されました | Mizuho | Buy |
| 2019-07-30 | ダウングレード | Guggenheim | Buy → Neutral |
| 2019-07-08 | 繰り返されました | Cantor Fitzgerald | Overweight |
| 2019-04-12 | 開始されました | Piper Jaffray | Overweight |
| 2019-03-29 | 開始されました | Robert W. Baird | Outperform |
すべてを表示
Uniqure N V (QURE) 最新ニュース
Why uniQure N.V. (UQ1) stock is trending on social mediaJuly 2025 Breakouts & AI Optimized Trade Strategies - newser.com
uniQure NV Faces Weak Start with 5.08% Gap Down Amid Market Concerns - Markets Mojo
How currency fluctuations impact uniQure N.V. stock - newser.com
Is uniQure N.V. stock a buy on dipsTrade Analysis Report & Daily Volume Surge Signals - newser.com
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of uniQure N.V.QURE - PR Newswire
Will uniQure N.V. stock deliver shareholder valueJuly 2025 Price Swings & Reliable Breakout Forecasts - newser.com
Is uniQure N.V. (UQ1) stock supported by strong fundamentals - newser.com
Reviewing uniQure (NASDAQ:QURE) and Biogen (NASDAQ:BIIB) - Defense World
Published on: 2025-11-19 17:01:52 - newser.com
Can uniQure N.V. stock hit record highs againTrade Volume Summary & Risk Controlled Stock Pick Alerts - newser.com
Predicting uniQure N.V. trend using moving averagesJuly 2025 PreEarnings & Reliable Intraday Trade Alerts - newser.com
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against uniQure N.V. (QURE) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire
uniQure N.V. (QURE) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
QURE Investigation: Kessler Topaz Meltzer & Check, LLP Encourages uniQure N.V. (NASDAQ: QURE) Investors With Significant Losses to Contact the Firm - FinancialContent
Wall Street Has a Positive Outlook on uniQure N.V. (QURE) Despite Challenges From The FDA - MSN
Summers Value Partners Established a Position in UniQure N.V. (QURE) in Q3 - Insider Monkey
Can uniQure N.V. (UQ1) stock sustain revenue momentumQuarterly Earnings Summary & Detailed Earnings Play Strategies - newser.com
Can uniQure N.V. stock hit analyst price targetsTrade Risk Report & Safe Entry Point Identification - newser.com
Volatility clustering patterns for uniQure N.V.Gold Moves & Real-Time Chart Breakout Alerts - newser.com
Is uniQure N.V. stock a bargain at current levelsPortfolio Performance Report & Daily Volume Surge Signals - newser.com
uniQure NV Faces Weak Start with 10.32% Gap Down Amid Market Concerns - Markets Mojo
uniQure N.V. Investigation: Kessler Topaz Meltzer & Check, LLP Encourages uniQure N.V. (NASDAQ: QURE) Investors With Significant Losses to Contact the Firm - FinancialContent
Do Rising Losses at uniQure (QURE) Reflect Strategic Investment or Escalating Cost Pressure? - simplywall.st
Hemophilia B Research Report 2025-2035: Market Led by UniQure, Pfizer, Novo Nordisk, HEMA Biologics, and Alnylam Pharmaceuticals as Next-Generation Therapies and R&D Investment Drive Innovation - Yahoo Finance
Bronstein, Gewirtz & Grossman, LLC Is Investigating uniQure N.V. (QURE) And Encourages Shareholders to Connect - ACCESS Newswire
How uniQure N.V. stock reacts to job market dataWeekly Risk Summary & Scalable Portfolio Growth Methods - newser.com
Ready to Jump After Recent Trade: uniQure N.V (QURE) - Setenews
What data driven models say about uniQure N.V.’s futureQuarterly Trade Report & Expert Verified Stock Movement Alerts - newser.com
How to read the order book for uniQure N.V.2025 Buyback Activity & Safe Capital Growth Stock Tips - newser.com
Risk adjusted return profile for uniQure N.V. analyzedJuly 2025 Sector Moves & Stepwise Trade Execution Plans - newser.com
uniQure N.V. Investigation Alert: Kessler Topaz Meltzer & Check, LLP Encourages uniQure N.V. (NASDAQ: QURE) Investors With Significant Losses to Contact the Firm - FinancialContent
uniQure NV Hits Day High with 15.18% Surge Amid Market Volatility - Markets Mojo
Uniqure N V (QURE) 財務データ
収益
当期純利益
現金流量
EPS
Uniqure N V (QURE) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Gut Robert | Director |
Nov 06 '25 |
Sale |
27.26 |
31,434 |
856,881 |
40,145 |
| Kaye Jack | Director |
Nov 04 '25 |
Option Exercise |
9.88 |
38,810 |
383,535 |
38,249 |
| Kaye Jack | Director |
Nov 04 '25 |
Sale |
30.34 |
38,810 |
1,177,517 |
20,439 |
1.38%
1.42%
大文字化:
|
ボリューム (24 時間):